Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin vs Cefepime for Fever and Neutropenia in Cancer Patients
NCT00020865Phase 3Unknown
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Sep 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in fever, neutropenia, Infection, sponsored by UCLA Jonsson Comprehensive Cancer Center. Status: unknown.
02
Drugs
levofloxacin
03
Conditions
feverneutropeniaInfection
Beyond the preview
Go deeper on NCT00020865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00020865.